Brief: Huakang Biomedical Updates On New Business Activity
22/07/2024 12:00
July 22 (Reuters) - Huakang Biomedical Holdings Co Ltd
8622.HK :
* INTENDS TO COMMENCE TRADING BUSINESS OF ENZYME- BASED
PRODUCTS
OF BESTYZYM + BESTLIFE GROUP (CHINA)
Further company coverage: 8622.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Joyzyme
See all newsChairman
Brief: Huakang Biomedical Trading In Co's Shares Halted
Brief: Huakang Biomedical Says Zhang Shuguang Resigns As Executive Director And Chairman
Brief: Huakang Biomedical Announces Zhang Yujing Appointed As Executive Director
Brief: Huakang Biomedical To Acquire 51% Interest In Hunan Keyue Biotechnology